Amer M. Johri, MD, MSc, FRCPC, FASE
SPECIALTY AND TITLE
Speciality: Cardiology, Echocardiography
Title: Professor and Director, Cardiovascular Imaging Network at Queen’s (CINQ), Queen’s University
2014-present Director of the Adult Congenital Heart Clinic, Cardiologist,
Kingston General Hospital, Kingston, Ontario
2013-present Cross Appointed Assistant Professor, Queen’s University
Department of Biomedical and Molecular Sciences
2022-present Professor, Queen’s University
Division of Cardiology, Department of Medicine
AREA OF RESEARCH
- Johri’s research interests include three-dimensional (3D) echocardiography, quality control in the echo lab, interventional echocardiography, and hand-held/point-of-care ultrasound (POCUS).
- His research focuses on non-invasive techniques to predict and diagnose atherosclerotic cardiovascular disease. This includes carotid intimal medial thickening, 3D strain and 3D stress testing, and cardiopulmonary POCUS. His current research encompasses patient-oriented research projects for screening of special populations, such as competitive athletes (sudden cardiac death in the athletes) and women (cardiovascular health, mental health), analysis of vulnerable atherosclerotic carotid plaque through 3D, composition, and novel ultrasound contrast applications.
MAJOR CONTRIBUTIONS TO SCIENCE AND/OR HEALTH CARE DELIVERY
- Development of Canada’s recommendations for the pre-participation screening of athletes: Johri led a national writing group to develop a Canadian Position Statement on the pre-participation screening of athletes, which was jointly published with the Canadian Cardiovasuclar Society and Canadian Heart Rhythm Society.
- Development of a novel 3D method for quantifying carotid plaque volume: Johri led the American Society of Echo (ASE) writing group on the Guidelines for the Assessment of Carotid Artery Plaque by Ultrasound.
- Protocolizing the use of POCUS: He is the first and lead author of an international guideline on the use of cardiopulmonary POCUS and its implications during the COVID-19 pandemic.